top of page

Biopharma Daily Stock Updates - 01/12/22

$XBI $100.60 -3.2%


Covid Updates

$OCGN +0.24 COVAXIN™ (BBV152) Booster Shown to Neutralize Both Omicron and Delta Variants of SARS-CoV-2 source

$NVAX -0.4% South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine source

Pipeline Updates

$PBYI -4.4% Puma Biotechnology’s NERLYNX® Included in Two Important NCCN Clinical Practice Guideline Updates for the Treatment of Breast Cancer source

$PGEN -4.6% Precigen Provides Pipeline and Corporate Updates at the 40th Annual J.P. Morgan Healthcare Conference source

$IMAB +3.8% I-Mab Announces First Patient Dosed in China Phase 2 Clinical Trial of Efineptakin Alfa in Combination with Pembrolizumab in Advanced Solid Tumors source

$HTBX +2.0% Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110. source.

$XENE -2.7% Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $15.0 Million Regulatory Milestone source.

$LGVN -10.2% Longeveron Announces Publication of Lomecel-B Phase 2b Trial Design in Journal of Frailty and Aging source.

$ARWR -3.3% Arrowhead Pharmaceuticals Initiates Phase 3 PALISADE Study of ARO-APOC3 for Treatment of Familial Chylomicronemia Syndrome source.

$KMPH -3.4% KemPharm to Host Investor Conference Call Detailing Plans for Pipeline Expansion source.

$CYT -10.3% Cyteir Therapeutics Announces First Patient Dosed in Phase 1 Combination Trial With CYT-0851 source.

$IMV +0.8% IMV Announces First Patient Dosed in the VITALIZE Phase 2B Clinical Study Evaluating its Lead Compound, MVP-S, in Combination with KEYTRUDA® (pembrolizumab) in Patients with r/r DLBCL source.

$ATAI -1.2% atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for PCN-101 R-ketamine Program source.

$HCM +1.3% HUTCHMED Receives Breakthrough Therapy Designation in China for HMPL-523 for Treatment of Primary Immune Thrombocytopenia source.

$LTRN +0.9% Lantern Pharma Expands Precision Oncology Collaboration with the National Cancer Institute - Accelerating Path to First in Human Clinical Trials for Drug Candidates LP-184 & LP-284 source.

Business Updates

$PCVX -6.8% Vaxcyte Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants source

$ORMP +0.3% Oramed Issues Annual Message to Shareholders. source.

$ACRX -5.5% AcelRx Pharmaceuticals Announces Publication of an Editorial by an Internationally Recognized Leader in Opioid-Sparing Surgery Highlighting the Potential Advantages of the Sufentanil Sublingual Tablet in Joint Replacement Surgery. source.

$IBRX -2.5% ImmunityBio Expands Manufacturing Capacity with State-of-the-Art Manufacturing Plant in New York for Global Pandemic Response and Preparedness. source.

$ATNX -7.3% Athenex Announces Agreement with ImmunityBio Regarding Dunkirk Manufacturing Facility. source.

$GRCL -2.9% Gracell Biotechnologies Unveils Innovation Center in U.S. source.


Posted by JM/EJ

bottom of page